Assembly Biosciences, Inc. (ASMB)
Assembly Biosciences Market Cap : 451.97M for Nov. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2026 | 451.97M |
| November 19, 2026 | 458.29M |
| November 18, 2026 | 456.05M |
| November 17, 2026 | 458.29M |
| November 16, 2026 | 433.64M |
| November 13, 2026 | 430.18M |
| November 12, 2026 | 411.03M |
| November 11, 2026 | 455.64M |
| November 10, 2026 | 434.87M |
| November 09, 2026 | 432.54M |
| November 06, 2026 | 405.34M |
| November 05, 2026 | 397.01M |
| November 04, 2026 | 394.43M |
| November 03, 2026 | 395.42M |
| November 02, 2026 | 387.28M |
| October 30, 2026 | 399.59M |
| October 29, 2026 | 414.08M |
| October 28, 2026 | 408.32M |
| October 27, 2026 | 402.96M |
| October 26, 2026 | 390.46M |
| October 23, 2026 | 393.83M |
| October 22, 2026 | 402.56M |
| October 21, 2026 | 406.14M |
| October 20, 2026 | 420.63M |
| October 19, 2026 | 400.18M |
| Date | Value |
|---|---|
| October 16, 2026 | 398.79M |
| October 15, 2026 | 408.32M |
| October 14, 2026 | 407.53M |
| October 13, 2026 | 403.76M |
| October 12, 2026 | 451.99M |
| October 09, 2026 | 467.08M |
| October 08, 2026 | 452.98M |
| October 07, 2026 | 455.56M |
| October 06, 2026 | 440.28M |
| October 05, 2026 | 451.40M |
| October 02, 2026 | 447.43M |
| October 01, 2026 | 456.16M |
| September 30, 2026 | 466.28M |
| September 29, 2026 | 466.08M |
| September 28, 2026 | 468.67M |
| September 25, 2026 | 469.86M |
| September 24, 2026 | 469.66M |
| September 23, 2026 | 475.81M |
| September 22, 2026 | 505.19M |
| September 21, 2026 | 504.99M |
| September 18, 2026 | 495.66M |
| September 17, 2026 | 503.01M |
| September 16, 2026 | 505.79M |
| September 15, 2026 | 518.29M |
| September 14, 2026 | 574.86M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Gilead Sciences, Inc. | 206.54B |
| ACADIA Pharmaceuticals, Inc. | 2.956B |
| Alnylam Pharmaceuticals, Inc. | 19.25B |
| Anika Therapeutics, Inc. | 177.20M |
| Savara, Inc. | 875.58M |
Market Cap Related Metrics
| PS Ratio | 6.076 |
| Price to Book Value | 1.513 |
| Price | 22.19 |
| Earnings Yield | -1.26% |